Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 11, 2026 08:30 ET | Source: VVT Med Inc.

VVT Med Expands into the Dominican Republic, Appointing Antilles Medical as Exclusive Distributor

VANCOUVER, BC, June 11, 2026 (GLOBE NEWSWIRE) -- VVT Med Inc. (TSXV: VVTM) ("VVT Med" or the "Company"), a developer of minimally invasive, non-thermal, non-tumescent ("NT-NT") solutions for venous...
June 11, 2026 08:30 ET | Source: Propanc Biopharma, Inc.

Propanc Biopharma Authorizes $5.0 Million Share Repurchase Program

"The foundation is clearly there and as a result, we believe we are undervalued significantly,” said Mr. James Nathanielsz, Propanc’s CEO
June 04, 2026 06:15 ET | Source: Novartis Pharma AG

Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years

Phase III ALIGN study results showed reduced rate of kidney function decline by ~34% with Vanrafia vs placebo, based on supportive eGFR slope analysis1Vanrafia reduced protein in urine by 38.3% vs...
June 02, 2026 05:30 ET | Source: Propanc Biopharma, Inc.

Propanc Biopharma’s CEO Attends Keynote Address, “Rejuvenation and Health: Science for an Ageing Society,” at the University of Granada, Spain

It was an honor to attend the keynote address of Dr. Izpisúa whose scientific interests and vision for the future of humanity are world renowned
June 01, 2026 09:00 ET | Source: Alpha Tau Medical Ltd.

Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT® Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting

Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT® Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting
June 01, 2026 01:15 ET | Source: Novartis Pharma AG

Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases

New Cosentyx® (secukinumab) data from REPLENISH, largest ever global Phase III trial in polymyalgia rheumatica, to be highlighted in oral sessionNew ianalumab interim results from Sjögren’s Phase III...
May 29, 2026 08:00 ET | Source: Medidata Solutions, Inc.

Medidata Champions Collaborative Scientific Advancement at ASCO with New Research on Oncology Protocol Optimization and CAR T Efficacy

NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, will present two poster presentations...
May 28, 2026 08:00 ET | Source: Actinogen Medical

Actinogen receives positive EMA scientific advice aligned with prior FDA guidance for its Alzheimer’s disease program

SYDNEY, May 28, 2026 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) today announces the successful outcome of its scheduled scientific advice meeting (written response) on Alzheimer’s...
May 28, 2026 08:00 ET | Source: Medidata Solutions, Inc.

Medidata’s Next-Gen AI Imaging Solution Delivers Unprecedented Speed and Precision for Clinical Trials

NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions, today unveiled its enhanced, AI-powered imaging solution, within the...
May 27, 2026 02:00 ET | Source: Predictive Health Intelligence

New study reveals promising new way to find serious liver disease earlier

Liver disease is often found late because people have no symptoms. This research shows how using existing NHS blood test data could help change that.